Disease
6 developments in the corpus
Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
Latest
Everything in the corpus, newest first.
AUG 20, 2026 · INTERVENTIONAL STUDY
ClinicalTrials.gov
This is a terminated study registration with feasibility endpoints only; no results are reported in the registry record, precluding any assessment of efficacy or harm.
AUG 20, 2026 · PHASE 2 TRIAL
ClinicalTrials.gov
Phase 2 trial in a recruiting stage with no results reported; measures a surrogate endpoint (ctDNA clearance) in an adjuvant minimal residual disease setting.
AUG 17, 2026 · PHASE 4 TRIAL
ClinicalTrials.gov
This is a Phase 4 interventional trial registration with no reported results; the study is not yet recruiting and carries planned outcome measures only.
AUG 10, 2026 · PHASE 3 TRIAL
ClinicalTrials.gov
This is a Phase 3 trial registration with no results posted; the study is still recruiting and has not yet reported outcomes.
AUG 10, 2026 · INTERVENTIONAL STUDY
ClinicalTrials.gov
This is a registry record for an active interventional feasibility study with no results yet posted; it describes planned enrollment and outcome measures only, making it a preliminary report of work in progress.
AUG 7, 2026 · PHASE 2 TRIAL
ClinicalTrials.gov
This is a Phase 2 screening trial registry record with no reported results; it describes planned enrollment and procedural outcomes only, not clinical efficacy or safety data.